Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2-3
|
pubmed:dateCreated |
1978-9-30
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0301-0244
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
30
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
245-53
|
pubmed:dateRevised |
2003-11-14
|
pubmed:meshHeading |
pubmed-meshheading:673928-Amphetamines,
pubmed-meshheading:673928-Animals,
pubmed-meshheading:673928-Dopamine,
pubmed-meshheading:673928-Halogens,
pubmed-meshheading:673928-Norepinephrine,
pubmed-meshheading:673928-Rats,
pubmed-meshheading:673928-Serotonin,
pubmed-meshheading:673928-Structure-Activity Relationship,
pubmed-meshheading:673928-Synaptosomes
|
pubmed:articleTitle |
The effect of para-halogenated amphetamines on brain monoamines.
|
pubmed:publicationType |
Journal Article
|